Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood

Bone Marrow Transplantation

Volumn 18, Issue SUPPL. 2, 1996, Pages 63-68

  Locatelli, Franco ^a   Zecca, Marco ^b   Niemeyer, Charlotte ^b   Angelucci, Emanuele ^b   Arcese, Giorgio ^b   Bender Gotze, Christine ^b   Bonetti, Federico ^b   Burdach, Stefan ^b   Dini, Giorgio ^b   Ebell, Wolfram ^b   Friedrich, Wilhelm ^b   Hasle, Henrik ^b   Hermann, Johann ^b   Jacobsen, Niels ^b   Klingebiel, Thomas ^b   Kremens, Bernhard ^b   Mann, Georg ^b   Miniere, Roberto ^b   Pession, Andrea ^b   Peters, Christine ^b   Paolucci, Paolo ^b   Rossetti, Flavio ^b   Schmid, Hans Jorg ^b   Stary, Jan ^b   Suttorp, Meinolf ^b   Uderzo, Cornelio ^b   Van't Veer Korthof, Elisabeth Th ^b   Vossen, Jaak ^b   Zimmermann, Martin ^b   more..

^a UNIVERSITY OF PAVIA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HEMOGLOBIN F;

ALLOGENIC BONE MARROW TRANSPLANTATION; BLAST CELL; CHILD; CONFERENCE PAPER; CYTOPENIA; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HUMAN; MORTALITY; MYELODYSPLASTIC SYNDROME; NEUROFIBROMATOSIS; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADOLESCENT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MYELODYSPLASTIC SYNDROMES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 10544241963     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Jacobs A. Human preleukaemia: Do we have a model ? Br J Cancer 1987;55:1-5.
2. Mufti GJ, Galton DAG. Myelodysplastic syndromes: natural history and features of prognostic importance. Clin Haematol 1986; 15: 953-71
3. Janssen JWG, Buschle M, Layton M, et al. Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. Blood 1989; 73: 248-54.
4. Jacobs A. Genetic lesions in preleukaemia. Leukemia 1991; 5: 277-282.
5. Luzzatto L. Leukemia is a genetic disorder of somatic cells. Haematologica 1990; 75: 105-108.
6. Blank J, Lange B. Preleukemia in children. J Pediatr 1981; 98: 565-570.
7. Bennet JM, Catovsky D, Daniel MT et al. Proposals for the classifications of the Myelodysplastic Syndromes. Br JHaematol 1982; 51: 189-199.
8. Gadner H, Haas OA. Experience in pediatric myelodysplastic syndromes. Hematol Oncol Clin North Am 1992; 6: 655-72.
9. Harm IM. Myelodysplastic syndrome. Arch Dis Child 1992; 67: 962-66.
10. Chessells JM. Myelodysplasia. In: Baillière's Clinical Haematolon 1991; 4 (2): 459-482.
11. Brandwein JM, Horsman DE, Eaves AC et al. Childhood myelodysplasia: suggested classification as myelodysplastic syndromes based on laboratory and clinical findings . Am J Ped Hematol/Oncol 1990; 12: 63-70.
12. Castro-Malaspina H, Schaison G, Passe S, et al. Subacute and chronic myelomonocytic leukemia in children (Juvenile CML). Cancer 1984; 54: 675-686.
13. Niemeyer C, Aricò M, Biondi A, et al. Chronic myelomonocytic leukemia in childhood, a retrospective analysis of 104 patients. Blood 1994; 84 (suppl 1): 56 (abstr).
14. O' Donnell MR, Nademanee AP, Snyder DS, et al, Bone marrow transplantation for myelodysplastic and myeloproliferative syndromes. J Clin Oncol 1987; 5: 1822-1826.
15. De Witte T, Zwann F, Hermans J, et al. Allogeneic bone marrow transplantation for secondary leukemia and myelodysplastic syndrome: a survey by the Leukema Working Party of the European Bone Marrow Transplantation Group (EBMTG). Br J Haematol 1990; 74; 151-155.
16. Guinan EC, Tarbell NJ, Tantravahi R, Weinstein HJ. Bone marrow transplantation for children with myelodysplastic syndromes. Blood 1989; 73: 619-622.
17. Anderson JE, Appelbaum FR, Fisher LD, et al. Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Pretreatment variables and outcome. Blood 1993; 82: 677-681.
18. Hirst WJR, Mufti GJ. Management of myelodysplastic syndromes. Br J Haematol 193; 84: 191-196.
19. De Witte T, Gratwohl A. Bone marrow transplantation for myelodysplastic syndrome and secondary leukemias. Br JHaematol 1993; 84: 361-364.
20. Locatelli F, Pession A, Bonetti F, et al. Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes. Leukemia 1994; 8: 844-849.
21. Sanders JE, Buckner CD, Thomas ED, et al. Allogeneic bone marrow tranplantation for children with juvenile chronic myeloid leukaemia. Blood 1988; 71:1144-1146.
22. Locatelli F, Pession A, Comoli P, et al. Role of allogeneic bone marrow transplantation from HLA-identical sibling or matched unrelated donor in the treatment of children with juvenile chronic myeloid leukemia. Br JHaematol 1996; 92: 49-54.
23. Tutschka PJ, Copelan EA, Klein JP: Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 1987; 70:1382-1388.
24. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J A fed 1993; 328: 593-598.
25. Locatelli F, Niemeyer C, Angelucci E, et al. Allogeneic bone marrow transplantation (BMT) for chronic myelomonocytic leukemia (CMML) in childhood: a report of the Europen Working Group on childhood myelodisplastic syndrome (EWOG-MDS). Blood 1995; 86: 93 (abstr).